David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss second-generation retinal disease therapies and how they may offer benefits for certain patients. These retina specialists also share their experience with the newer agents through challenging real-world case studies.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Click here to view the webinar event, which includes images from the talk.

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.